Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New Haven, Connecticut
- Most recent report
- 8-K, filed Sep 14, 2026
- Incorporated
- Delaware
- Filings on record
- 676 filings
- On EDGAR
- CIK 1566044
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 36
News 8 of 133
Prospectuses and Registrations 8 of 34
- 424B5 Prospectus supplement for an offering Sep 11, 2026
- 424B5 Prospectus supplement for an offering Sep 11, 2026
- POS AM Post-effective amendment to a registration Aug 14, 2026
- 424B3 Prospectus supplement for an offering Jun 15, 2026
- S-4/A Registration statement for a merger or exchange, amended Jun 3, 2026
- S-4/A Registration statement for a merger or exchange, amended Apr 28, 2026
- S-4 Registration statement for a merger or exchange Mar 31, 2026
- S-8 Registration statement for an employee plan Dec 19, 2024
Proxies 8 of 20
- DEF 14A Proxy statement for a shareholder vote Nov 12, 2025
- DEF 14A Proxy statement for a shareholder vote Nov 12, 2024
- DEF 14A Proxy statement for a shareholder vote Nov 13, 2023
- DEF 14A Proxy statement for a shareholder vote Nov 25, 2022
- PRE 14A Preliminary proxy statement Nov 14, 2022
- DEFA14A Extra proxy material Jul 28, 2022
- DEFA14A Extra proxy material Jul 19, 2022
- DEFA14A Extra proxy material Jul 7, 2022
Ownership 8 of 386
- SCHEDULE 13G Large holder reported a passive stake Sep 17, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 7, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- SCHEDULE 13D Large holder reported an active stake Aug 5, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 4, 2026
Other 8 of 67
- EFFECT Notice that a registration became effective Aug 19, 2026
- 425 Jul 14, 2026
- 425 Jul 10, 2026
- ARS Annual report sent to shareholders Jun 16, 2026
- EFFECT Notice that a registration became effective Jun 15, 2026
- DRS Draft registration statement, submitted confidentially Jan 30, 2026
- 425 Jan 30, 2026
- 425 Dec 17, 2025
Everything here comes from Yarrow Bioscience, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.